Up a level |
(2022) A Post-Marketing Surveillance Study to Evaluate the Safety Profile of AlvotereⓇ (Docetaxel) in Iranian Patients Diagnosed with Different Types of Cancers Receiving Chemotherapy. Current Therapeutic Research - Clinical and Experimental. ISSN 0011393X (ISSN)